Bessemer Group Inc. cut its position in Exactech, Inc. (NASDAQ:EXAC) by 38.5% in the 4th quarter, Holdings Channel reports. The firm owned 12,000 shares of the medical equipment provider’s stock after selling 7,500 shares during the period. Bessemer Group Inc.’s holdings in Exactech were worth $593,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Highbridge Capital Management LLC bought a new position in Exactech in the third quarter valued at about $201,000. AMP Capital Investors Ltd bought a new position in Exactech in the third quarter valued at about $215,000. Voya Investment Management LLC bought a new position in Exactech in the second quarter valued at about $243,000. Paragon Capital Management Ltd acquired a new stake in shares of Exactech in the fourth quarter valued at about $277,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Exactech by 3.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock valued at $278,000 after buying an additional 289 shares during the period. Hedge funds and other institutional investors own 58.88% of the company’s stock.

EXAC has been the subject of several recent research reports. ValuEngine cut Exactech from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. BidaskClub cut Exactech from a “hold” rating to a “sell” rating in a research note on Saturday, January 20th. Zacks Investment Research raised Exactech from a “sell” rating to a “hold” rating in a research note on Tuesday, December 26th. Gabelli cut Exactech from a “buy” rating to a “hold” rating in a research note on Tuesday, October 24th. Finally, Robert W. Baird set a $34.00 price target on Exactech and gave the company a “buy” rating in a research note on Sunday, October 15th. Six equities research analysts have rated the stock with a hold rating, Exactech has an average rating of “Hold” and a consensus price target of $49.00.

Shares of Exactech, Inc. (NASDAQ:EXAC) opened at $49.30 on Monday. The firm has a market capitalization of $708.25, a PE ratio of 4,930.00, a PEG ratio of 3.64 and a beta of 0.90. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.08 and a quick ratio of 2.09. Exactech, Inc. has a one year low of $23.75 and a one year high of $50.95.

TRADEMARK VIOLATION NOTICE: This report was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://theolympiareport.com/2018/02/12/bessemer-group-inc-reduces-holdings-in-exactech-inc-exac.html.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.